{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:09:13Z","timestamp":1789520953426,"version":"build-2803163510"},"reference-count":193,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ50544"],"award-info":[{"award-number":["2025JJ50544"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189683","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T21:57:35Z","timestamp":1786917455000},"page":"189683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability"],"prefix":"10.1016","volume":"1881","author":[{"given":"Zhihao","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2168-8054","authenticated-orcid":false,"given":"Chunmei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5486","key":"10.1016\/j.bbcan.2026.189683_bb0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/253062a0","article-title":"Polyamines stabilise DNA folds","volume":"253","author":"Flink","year":"1975","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189683_bb0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","article-title":"Polyamine metabolism and cancer: treatments, challenges and opportunities","volume":"18","author":"Casero","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189683_bb0015","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1158\/1078-0432.CCR-15-2539","article-title":"Polyamine antagonist therapies inhibit neuroblastoma initiation and progression","volume":"22","author":"Evageliou","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189683_bb0020","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1042\/BCJ20160383","article-title":"Targeting polyamine metabolism for cancer therapy and prevention","volume":"473","author":"Murray-Stewart","year":"2016","journal-title":"Biochem. J."},{"issue":"7661","key":"10.1016\/j.bbcan.2026.189683_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature22964","article-title":"mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer","volume":"547","author":"Zabala-Letona","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189683_bb0030","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.onc.1209198","article-title":"Elevated levels of ornithine decarboxylase cooperate with Raf\/ERK activation to convert normal keratinocytes into invasive malignant cells","volume":"25","author":"Hayes","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/CAD.0000000000000465","article-title":"Extracellular polyamines-induced proliferation and migration of cancer cells by ODC, SSAT, and Akt1-mediated pathway","volume":"28","author":"Dai","year":"2017","journal-title":"Anti-Cancer Drugs"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189683_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158171","article-title":"The many faces of hypusinated eIF5A: cell context-specific effects of the hypusine circuit and implications for human health","volume":"25","author":"Nakanishi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0045","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41467-023-37305-2","article-title":"Cryo-EM structure of human eIF5A-DHS complex reveals the molecular basis of hypusination-associated neurodegenerative disorders","volume":"14","author":"W\u0105tor","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13578-021-00733-y","article-title":"The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles","volume":"11","author":"Tauc","year":"2021","journal-title":"Cell Biosci."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189683_bb0055","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1074\/jbc.M601081200","article-title":"Deoxyhypusine hydroxylase is a Fe(II)-dependent, HEAT-repeat enzyme. Identification of amino acid residues critical for Fe(II) binding and catalysis [corrected]","volume":"281","author":"Kim","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.str.2015.03.002","article-title":"Crystal structure of the peroxo-diiron(III) intermediate of deoxyhypusine hydroxylase, an oxygenase involved in hypusination","volume":"23","author":"Han","year":"2015","journal-title":"Structure"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126340","article-title":"Structural insights into the mechanisms underlying polyaminopathies","volume":"25","author":"Wu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1073\/pnas.0509348102","article-title":"Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme","volume":"103","author":"Park","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0075","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ajhg.2022.06.010","article-title":"Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder","volume":"109","author":"Ziegler","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbcan.2026.189683_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115440","article-title":"Hypusination-induced DHPS\/eIF5A pathway as a new therapeutic strategy for human diseases: a mechanistic review and structural classification of DHPS inhibitors","volume":"167","author":"Guo","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0085","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1073\/pnas.78.5.2869","article-title":"Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor","volume":"78","author":"Park","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189683_bb0090","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.1008150108","article-title":"Eukaryotic translation initiation factor (eIF) 5A stimulates protein synthesis in Saccharomyces cerevisiae","volume":"108","author":"Henderson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0095","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1093\/nar\/gkx479","article-title":"eIF5A facilitates translation termination globally and promotes the elongation of many non polyproline-specific tripeptide sequences","volume":"45","author":"Pelechano","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.molcel.2017.03.003","article-title":"eIF5A functions globally in translation elongation and termination","volume":"66","author":"Schuller","year":"2017","journal-title":"Mol. Cell"},{"issue":"7243","key":"10.1016\/j.bbcan.2026.189683_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature08034","article-title":"Hypusine-containing protein eIF5A promotes translation elongation","volume":"459","author":"Saini","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2019.05.003","article-title":"Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation","volume":"30","author":"Puleston","year":"2019","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1172\/JCI200521949","article-title":"Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy","volume":"115","author":"Hauber","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ardp.201500323","article-title":"Linker-region modified derivatives of the deoxyhypusine synthase inhibitor CNI-1493 suppress HIV-1 replication","volume":"349","author":"Schr\u00f6der","year":"2016","journal-title":"Arch. Pharm."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41467-021-21053-2","article-title":"Impaired eIF5A function causes a Mendelian disorder that is partially rescued in model systems by spermidine","volume":"12","author":"Faundes","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajhg.2018.12.017","article-title":"Recessive rare variants in deoxyhypusine synthase, an enzyme involved in the synthesis of hypusine, are associated with a neurodevelopmental disorder","volume":"104","author":"Ganapathi","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101333","article-title":"Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice","volume":"297","author":"Kar","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0140","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1742-4658.2006.05135.x","article-title":"Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells","volume":"273","author":"Clement","year":"2006","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gutjnl-2011-300207","article-title":"Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition","volume":"61","author":"Zhu","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0150","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/hep.23451","article-title":"Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma","volume":"51","author":"Tang","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119229","article-title":"Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer","volume":"10","author":"Meng","year":"2015","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0160","first-page":"4269","article-title":"eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT","volume":"10","author":"Sun","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1053\/j.gastro.2023.05.041","article-title":"Hypusination maintains intestinal homeostasis and prevents colitis and carcinogenesis by enhancing aldehyde detoxification","volume":"165","author":"Gobert","year":"2023","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41419-020-03174-6","article-title":"Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation","volume":"11","author":"Coni","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0175","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-024-02031-w","article-title":"Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma","volume":"23","author":"Park","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molcel.2013.04.021","article-title":"eIF5A promotes translation of polyproline motifs","volume":"51","author":"Gutierrez","year":"2013","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0185","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41419-022-05033-y","article-title":"Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-70566-1","article-title":"Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness","volume":"17","author":"Kahi","year":"2026","journal-title":"Nat. Commun."},{"issue":"7407","key":"10.1016\/j.bbcan.2026.189683_bb0195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189683_bb0200","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1073\/pnas.90.16.7804","article-title":"The ornithine decarboxylase gene is a transcriptional target of c-Myc","volume":"90","author":"Bello-Fernandez","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0205","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1158\/0008-5472.CAN-17-2873","article-title":"KRAS Oncoprotein expression is regulated by a self-governing eIF5A-PEAK1 feed-forward regulatory loop","volume":"78","author":"Fujimura","year":"2018","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0210","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-16-2594","article-title":"eIF5A-PEAK1 signaling regulates YAP1\/TAZ protein expression and pancreatic cancer cell growth","volume":"77","author":"Strnadel","year":"2017","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189683_bb0215","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1158\/0008-5472.CAN-14-1031","article-title":"A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer","volume":"74","author":"Fujimura","year":"2014","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189683_bb0220","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1128\/MCB.25.10.4262-4271.2005","article-title":"Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1","volume":"25","author":"Murata","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112520","article-title":"Differential cell-cycle control by oscillatory versus sustained Hes1 expression via p21","volume":"42","author":"Maeda","year":"2023","journal-title":"Cell Rep."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189683_bb0230","first-page":"8323","article-title":"Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis","volume":"63","author":"Qi","year":"2003","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0235","doi-asserted-by":"crossref","first-page":"R605","DOI":"10.1186\/bcr920","article-title":"Role of notch signaling in cell-fate determination of human mammary stem\/progenitor cells","volume":"6","author":"Dontu","year":"2004","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0240","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/path.6139","article-title":"Simultaneous activation of Kras-Akt and notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway","volume":"260","author":"Namikawa","year":"2023","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0245","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41419-023-06109-z","article-title":"Targeted inhibition of eIF5A(hpu) suppresses tumor growth and polarization of M2-like tumor-associated macrophages in oral cancer","volume":"14","author":"Zeng","year":"2023","journal-title":"Cell Death Dis."},{"issue":"6456","key":"10.1016\/j.bbcan.2026.189683_bb0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.bbcan.2026.189683_bb0255","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-16-2055","article-title":"p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy","volume":"76","author":"El-Deiry","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0260","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13402-014-0201-9","article-title":"Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21\/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients","volume":"37","author":"Bandino","year":"2014","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"8085","key":"10.1016\/j.bbcan.2026.189683_bb0265","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-025-09564-0","article-title":"Reprogramming neuroblastoma by diet-enhanced polyamine depletion","volume":"646","author":"Cherkaoui","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0270","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0275","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0280","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41598-025-85466-5","article-title":"Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGF\u03b2 pathway","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189683_bb0290","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189683_bb0295","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41419-021-04166-w","article-title":"TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2\/CCR2 signaling","volume":"12","author":"Tu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0300","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41419-020-2435-y","article-title":"CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating \u03b2-catenin\/STAT3 signaling","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189683_bb0305","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1158\/1078-0432.CCR-18-3421","article-title":"Breast Phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression, which can be inhibited by CCR5 inhibition therapy","volume":"25","author":"Nie","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0310","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1535-7163.MCT-17-0507","article-title":"CCL26 participates in the PRL-3-induced promotion of colorectal cancer invasion by stimulating tumor-associated macrophage infiltration","volume":"17","author":"Lan","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"40","key":"10.1016\/j.bbcan.2026.189683_bb0315","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1038\/onc.2016.71","article-title":"The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma","volume":"35","author":"Muramatsu","year":"2016","journal-title":"Oncogene"},{"issue":"50","key":"10.1016\/j.bbcan.2026.189683_bb0320","doi-asserted-by":"crossref","first-page":"29907","DOI":"10.1074\/jbc.M115.687418","article-title":"Eukaryotic translation initiation factor 5A (EIF5A) regulates pancreatic Cancer metastasis by modulating RhoA and rho-associated kinase (ROCK) protein expression levels","volume":"290","author":"Fujimura","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0325","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/s41467-024-51901-w","article-title":"P53-dependent hypusination of eIF5A affects mitochondrial translation and senescence immune surveillance","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0330","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202404094","article-title":"eIF5A controls mitoprotein import by relieving ribosome stalling at TIM50 translocase mRNA","volume":"223","author":"Barba-Aliaga","year":"2024","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0335","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.7150\/ijbs.44943","article-title":"Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis","volume":"16","author":"Li","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomed."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0345","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0350","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","article-title":"Mitochondrial metabolism and cancer therapeutic innovation","volume":"10","author":"Du","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0355","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0360","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0365","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00284682","article-title":"The HYP2 gene of Saccharomyces cerevisiae is essential for aerobic growth: characterization of different isoforms of the hypusine-containing protein Hyp2p and analysis of gene disruption mutants","volume":"241","author":"W\u00f6hl","year":"1993","journal-title":"Mol. Gen. Genet."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189683_bb0370","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.02.029","article-title":"Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189683_bb0375","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1158\/1078-0432.CCR-14-1953","article-title":"XPO1\/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A","volume":"21","author":"Miyake","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189683_bb0380","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1038\/ncomms11952","article-title":"Structure of the exportin Xpo4 in complex with RanGTP and the hypusine-containing translation factor eIF5A","volume":"7","author":"Aksu","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0385","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/jcp.25370","article-title":"Alternative start codon connects eIF5A to mitochondria","volume":"231","author":"Pereira","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0390","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jcb.29884","article-title":"Alternative human eIF5A protein isoform plays a critical role in mitochondria","volume":"122","author":"Pereira","year":"2021","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0395","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.trecan.2021.05.003","article-title":"Autophagy regulates stress responses, metabolism, and anticancer immunity","volume":"7","author":"White","year":"2021","journal-title":"Trends Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0400","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0405","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846072","article-title":"eIF5A is required for autophagy by mediating ATG3 translation","volume":"19","author":"Lubas","year":"2018","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0415","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0420","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0425","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Jim\u00e9nez","year":"2000","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189683_bb0430","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng1855","article-title":"Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster","volume":"38","author":"Dews","year":"2006","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189683_bb0435","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/nar\/28.11.2268","article-title":"Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA","volume":"28","author":"Janz","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189683_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114831","article-title":"ERK1\/2 interaction with DHPS regulates eIF5A deoxyhypusination independently of ERK kinase activity","volume":"43","author":"Becker","year":"2024","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0955-0674(00)00194-0","article-title":"HIF-1 and mechanisms of hypoxia sensing","volume":"13","author":"Semenza","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0450","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0455","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbrc.2016.01.024","article-title":"Eukaryotic translation initiation factor 5A (eIF5A) is essential for HIF-1\u03b1 activation in hypoxia","volume":"470","author":"Tariq","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0460","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s12276-024-01214-1","article-title":"Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1\u03b1 to induce the polarization of tumor-associated macrophages","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189683_bb0465","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/onc.2014.228","article-title":"Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells","volume":"34","author":"Watnick","year":"2015","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189683_bb0470","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1158\/0008-5472.CAN-10-2412","article-title":"The myc-miR-17\u223c92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors","volume":"70","author":"Dews","year":"2010","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0475","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/gcc.21943","article-title":"The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification","volume":"51","author":"Italiano","year":"2012","journal-title":"Genes Chromosom. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0480","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/2326-6066.CIR-13-0120-T","article-title":"Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment","volume":"2","author":"Hayes","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0485","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1038\/s41467-022-35252-y","article-title":"Translation factor eIF5a is essential for IFN\u03b3 production and cell cycle regulation in primary CD8(+) T lymphocytes","volume":"13","author":"Tan","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/medsci6010022","article-title":"Role of polyamines in immune cell functions","volume":"6","author":"Hesterberg","year":"2018","journal-title":"Med. Sci."},{"issue":"6282","key":"10.1016\/j.bbcan.2026.189683_bb0495","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0500","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","article-title":"YAP\/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis","volume":"24","author":"Li","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"33","key":"10.1016\/j.bbcan.2026.189683_bb0505","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402450","article-title":"DHPS-mediated hypusination regulates METTL3 self-m6A-methylation modification to promote melanoma proliferation and the development of novel inhibitors","volume":"11","author":"Guo","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189683_bb0510","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biomaterials.2015.11.022","article-title":"Mg(II)-catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo","volume":"81","author":"Chen","year":"2016","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0515","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BCJ20170597","article-title":"Synergistic drug combination GC7\/DFMO suppresses hypusine\/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma","volume":"475","author":"Schultz","year":"2018","journal-title":"Biochem. J."},{"issue":"477","key":"10.1016\/j.bbcan.2026.189683_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau1099","article-title":"Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma","volume":"11","author":"Gamble","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189683_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105576","article-title":"Phase I dose-escalation trial of AMXT 1501 dicaprate plus difluoromethylornithine: a dual-agent approach targeting immunosuppressive polyamine metabolism","volume":"10","author":"Piha-Paul","year":"2025","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0530","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.22.02875","article-title":"Eflornithine as postimmunotherapy maintenance in high-risk neuroblastoma: externally controlled, propensity score-matched survival outcome comparisons","volume":"42","author":"Oesterheld","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0535","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tips.2024.04.005","article-title":"Eflornithine for treatment of high-risk neuroblastoma","volume":"45","author":"Jiang","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0540","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","article-title":"Polyamines in cancer: integrating organismal metabolism and antitumour immunity","volume":"22","author":"Holbert","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189683_bb0545","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1535-7163.MCT-19-1116","article-title":"Polyamine blocking therapy decreases survival of tumor-infiltrating immunosuppressive myeloid cells and enhances the antitumor efficacy of PD-1 blockade","volume":"19","author":"Alexander","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0550","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0090-4295(86)90154-8","article-title":"Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer","volume":"28","author":"Herr","year":"1986","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0555","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/07357909009017559","article-title":"Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an eastern cooperative oncology group (ECOG) study","volume":"8","author":"Winter","year":"1990","journal-title":"Cancer Investig."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020996","article-title":"Polyamine signal through HCC microenvironment: a key regulator of mitochondrial preservation and turnover in TAMs","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0565","doi-asserted-by":"crossref","DOI":"10.1186\/s40659-026-00679-w","article-title":"The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRAS(G12C) mutation","volume":"59","author":"Martin-Martin","year":"2026","journal-title":"Biol. Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0570","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1054\/bjoc.2000.1305","article-title":"A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours","volume":"83","author":"Paridaens","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0575","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/1078-0432.CCR-0977-03","article-title":"Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin\u2019s lymphoma: results from a phase II multicenter study","volume":"10","author":"Pless","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189683_bb0580","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/bse0460006","article-title":"Design of polyamine-based therapeutic agents: new targets and new directions","volume":"46","author":"Senanayake","year":"2009","journal-title":"Essays Biochem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189683_bb0585","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/0006-2952(93)90449-7","article-title":"Effects of inhibitors of spermidine synthase and spermine synthase on polyamine synthesis in rat tissues","volume":"45","author":"Shirahata","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189683_bb0590","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-555","article-title":"Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm","volume":"10","author":"Cervelli","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0595","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00280-020-04082-4","article-title":"A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors","volume":"85","author":"Murray Stewart","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0600","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00280-020-04201-1","article-title":"A phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma","volume":"87","author":"Murray Stewart","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189683_bb0605","series-title":"Phase 1A\/1B Dose Escalation and Expansion Study of SBP-101 in Combination with nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma","year":"2018"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189683_bb0610","doi-asserted-by":"crossref","DOI":"10.3390\/cells11244100","article-title":"Treatment with MDL 72527 ameliorated clinical symptoms, retinal ganglion cell loss, optic nerve inflammation, and improved visual acuity in an experimental model of multiple sclerosis","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0615","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1158\/1940-6207.CAPR-14-0176","article-title":"Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling","volume":"7","author":"Mohammed","year":"2014","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0620","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1940-6207.CAPR-09-0096","article-title":"A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer","volume":"3","author":"Bailey","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189044","article-title":"Ornithine decarboxylase as a therapeutic target for endometrial cancer","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0630","first-page":"1323","article-title":"Inhibition of ornithine decarboxylase alters the roscovitine-induced mitochondrial-mediated apoptosis in MCF-7 breast cancer cells","volume":"5","author":"Arisan","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0635","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10549-012-2235-x","article-title":"Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells","volume":"136","author":"Zhu","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/medsci6010012","article-title":"Alpha-Difluoromethylornithine, an irreversible inhibitor of polyamine biosynthesis, as a therapeutic strategy against hyperproliferative and infectious diseases","volume":"6","author":"LoGiudice","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.bbcan.2026.189683_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101215","article-title":"High-dose DFMO alters protein translation in neuroblastoma","volume":"68","author":"Franson","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189683_bb0650","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67097","article-title":"Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease","volume":"10","author":"Rajasekaran","year":"2021","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0655","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/dmcn.15687","article-title":"Bachmann-Bupp syndrome and treatment","volume":"66","author":"Bachmann","year":"2024","journal-title":"Dev. Med. Child Neurol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0660","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/pde.15187","article-title":"Improvement of dermatological symptoms in patients with Bachmann\u2013Bupp syndrome using difluoromethylornithine treatment","volume":"40","author":"Afrin","year":"2023","journal-title":"Pediatr. Dermatol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0665","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.1997.391","article-title":"Polyamine deprivation prevents the development of tumour-induced immune suppression","volume":"76","author":"Chamaillard","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0670","first-page":"890","article-title":"Decarboxylated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxylase inhibition by alpha-difluoromethylornithine","volume":"47","author":"Haegele","year":"1987","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0675","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/iub.1237","article-title":"The function of spermine","volume":"66","author":"Pegg","year":"2014","journal-title":"IUBMB Life"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189683_bb0680","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/jm801580w","article-title":"Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor","volume":"52","author":"Burns","year":"2009","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0685","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41467-021-20896-z","article-title":"Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas","volume":"12","author":"Khan","year":"2021","journal-title":"Nat. Commun."},{"issue":"766","key":"10.1016\/j.bbcan.2026.189683_bb0690","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn1285","article-title":"Spermidine metabolism regulates leukemia stem and progenitor cell function through KAT7 expression in patient-derived mouse models","volume":"16","author":"Rondeau","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"6374","key":"10.1016\/j.bbcan.2026.189683_bb0695","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2788","article-title":"Spermidine in health and disease","volume":"359","author":"Madeo","year":"2018","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0700","first-page":"3210","article-title":"CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity","volume":"54","author":"Regenass","year":"1994","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0705","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11306-025-02278-4","article-title":"SAM486A-induced inhibition of AMD1: metabolic and epigenetic implications in non-small cell lung cancer cells","volume":"21","author":"Mu\u00f1oz-Uribe","year":"2025","journal-title":"Metabolomics"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0710","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-24-3217","article-title":"A genome-wide synthetic lethal screen identifies spermidine synthase as a target to enhance erdafitinib efficacy in FGFR-mutant bladder cancer","volume":"85","author":"Yu","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189683_bb0715","article-title":"Polyamine metabolism in cancer: drivers of immune evasion, ferroptosis and therapy resistance","volume":"27","author":"Chenna","year":"2025","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189683_bb0720","article-title":"Polyamine metabolism and anti-tumor immunity","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189683_bb0725","first-page":"3715","article-title":"Correlations between polyamine analogue-induced increases in spermidine\/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines","volume":"51","author":"Porter","year":"1991","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189683_bb0730","first-page":"3829","article-title":"Differential induction of spermidine\/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues","volume":"49","author":"Casero","year":"1989","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189683_bb0735","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1021\/jm980172v","article-title":"Conformationally restricted analogues of 1N,12N-bisethylspermine: synthesis and growth inhibitory effects on human tumor cell lines","volume":"41","author":"Reddy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189683_bb0740","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-7-77","article-title":"A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047","volume":"7","author":"Kuo","year":"2009","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0745","first-page":"161","article-title":"Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047","volume":"6","author":"Ignatenko","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0750","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1021\/jm990375z","article-title":"Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives","volume":"43","author":"Bergeron","year":"2000","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126798","article-title":"Expanded potential of the polyamine analogue SBP-101 (diethyl dihydroxyhomospermine) as a modulator of polyamine metabolism and cancer therapeutic","volume":"23","author":"Holbert","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0760","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1021\/acs.jmedchem.9b01979","article-title":"Discovery of novel allosteric inhibitors of deoxyhypusine synthase","volume":"63","author":"Tanaka","year":"2020","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0765","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/acsmedchemlett.0c00331","article-title":"New series of potent allosteric inhibitors of deoxyhypusine synthase","volume":"11","author":"Tanaka","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0770","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040522","article-title":"Half way to Hypusine-structural basis for substrate recognition by human Deoxyhypusine synthase","volume":"10","author":"W\u0105tor","year":"2020","journal-title":"Biomolecules"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189683_bb0775","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.yexcr.2013.08.010","article-title":"N1-guanyl-1,7-diaminoheptane (GC7) enhances the therapeutic efficacy of doxorubicin by inhibiting activation of eukaryotic translation initiation factor 5A2 (eIF5A2) and preventing the epithelial-mesenchymal transition in hepatocellular carcinoma cells","volume":"319","author":"Lou","year":"2013","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189683_bb0780","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1128\/IAI.68.9.5329-5334.2000","article-title":"Suppression of macrophage activation with CNI-1493 increases survival in infant rats with systemic Haemophilus influenzae infection","volume":"68","author":"Granert","year":"2000","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0785","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00436-008-0891-x","article-title":"The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria-inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase","volume":"102","author":"Specht","year":"2008","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189683_bb0790","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1007\/s10637-012-9810-1","article-title":"Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias","volume":"30","author":"Ziegler","year":"2012","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbcan.2026.189683_bb0795","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2119\/molmed.2016.00163","article-title":"The multi-target effects of CNI-1493: convergence of anti-amylodogenic and anti-inflammatory properties in animal models of Alzheimer's disease","volume":"22","author":"Sankowski","year":"2016","journal-title":"Mol. Med."},{"issue":"2\u20133","key":"10.1016\/j.bbcan.2026.189683_bb0800","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00726-011-0984-1","article-title":"Effects of novel C-methylated spermidine analogs on cell growth via hypusination of eukaryotic translation initiation factor 5A","volume":"42","author":"Hyv\u00f6nen","year":"2012","journal-title":"Amino Acids"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189683_bb0805","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00403-015-1592-9","article-title":"N(1)-methylspermidine, a stable spermidine analog, prolongs anagen and regulates epithelial stem cell functions in human hair follicles","volume":"307","author":"Ramot","year":"2015","journal-title":"Arch. Dermatol. Res."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189683_bb0810","doi-asserted-by":"crossref","first-page":"13356","DOI":"10.1021\/acs.jmedchem.1c00582","article-title":"Novel allosteric inhibitors of deoxyhypusine synthase against malignant melanoma: design, synthesis, and biological evaluation","volume":"64","author":"Liu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189683_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118061","article-title":"In silico design, synthesis and biological evaluation of 2-benzyl-5-(2-methoxybenzyl)-1,3,4-oxadiazole derivates as allosteric deoxyhypusine synthase (DHPS) inhibitors for melanoma treatment","volume":"299","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0820","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s42004-026-01897-9","article-title":"Crystallographic fragment screening supports tool compound discovery and reveals conformational flexibility in human deoxyhypusine synthase","volume":"9","author":"Wilk","year":"2026","journal-title":"Commun. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0825","article-title":"Deoxyhypusine synthase mutations alter the post-translational modification of eukaryotic initiation factor 5A resulting in impaired human and mouse neural homeostasis","volume":"4","author":"Padgett","year":"2023","journal-title":"HGG Adv."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13041-024-01139-w","article-title":"Deoxyhypusine synthase deficiency syndrome zebrafish model: aberrant morphology, epileptiform activity, and reduced arborization of inhibitory interneurons","volume":"17","author":"Shojaeinia","year":"2024","journal-title":"Mol. Brain"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0835","first-page":"963","article-title":"A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation","volume":"7","author":"Sievert","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189683_bb0840","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2009-03-209965","article-title":"Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells","volume":"114","author":"Eberhard","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189683_bb0845","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.34545","article-title":"Deoxyhypusine hydroxylase: a novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma","volume":"153","author":"Ofek","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189683_bb0850","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1021\/acsomega.1c00273","article-title":"Synthetic derivatives of ciclopirox are effective inhibitors of Cryptococcus neoformans","volume":"6","author":"Lin","year":"2021","journal-title":"ACS Omega"},{"issue":"4 Suppl","key":"10.1016\/j.bbcan.2026.189683_bb0855","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2026.189683_bb0860","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1461-1244.2004.02409.x","article-title":"Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial","volume":"43","author":"Lebwohl","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.bbcan.2026.189683_bb0865","doi-asserted-by":"crossref","DOI":"10.3390\/app142411859","article-title":"Ciclopirox and ciclopirox olamine: antifungal agents in dermatology with expanding therapeutic potential","volume":"14","author":"Mucha","year":"2024","journal-title":"Appl. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0870","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.23640","article-title":"Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies","volume":"89","author":"Minden","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0875","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/jpet.119.257972","article-title":"Preclinical pharmacokinetics of Fosciclopirox, a novel treatment of urothelial cancers, in rats and dogs","volume":"370","author":"Weir","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0880","article-title":"Synergistic anti-tumor activity of ciclopirox olamine and metformin in triple-negative breast cancer","volume":"13","author":"Wu","year":"2026","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189683_bb0885","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/2040620712450252","article-title":"Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia","volume":"3","author":"Jamuar","year":"2012","journal-title":"Ther. Adv. Hematol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0890","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.2006.05984.x","article-title":"Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease","volume":"133","author":"Chan","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189683_bb0895","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/0008-5472.CAN-13-0474","article-title":"Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation","volume":"74","author":"M\u00e9min","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0900","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/gyno.2001.6570","article-title":"Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells","volume":"85","author":"Simonart","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0905","first-page":"659","article-title":"Modulation of cell cycle regulatory protein expression and suppression of tumor growth by mimosine in nude mice","volume":"17","author":"Chang","year":"2000","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0910","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41467-024-54838-2","article-title":"Girolline is a sequence context-selective modulator of eIF5A activity","volume":"16","author":"Schneider-Poetsch","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0915","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01252-25","article-title":"Role of g5Rp in African swine fever virus replication: disruption of host translation and autophagy","volume":"100","author":"Xu","year":"2026","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0920","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1038\/s41467-022-32788-x","article-title":"Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0925","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12935-021-02115-3","article-title":"LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p\/eIF5A axis","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189683_bb0930","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/mt.2014.24","article-title":"SNS01-T modulation of eIF5A inhibits B-cell cancer progression and synergizes with bortezomib and lenalidomide","volume":"22","author":"Francis","year":"2014","journal-title":"Mol. Ther."},{"issue":"42","key":"10.1016\/j.bbcan.2026.189683_bb0935","doi-asserted-by":"crossref","first-page":"35251","DOI":"10.1074\/jbc.M112.374686","article-title":"Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells","volume":"287","author":"Epis","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0940","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1038\/s41467-025-66531-z","article-title":"Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation","volume":"16","author":"Sfakianos","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189683_bb0945","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/2643-3230.BCD-22-0162","article-title":"The polyamine-hypusine circuit controls an oncogenic translational program essential for malignant conversion in MYC-driven lymphoma","volume":"4","author":"Nakanishi","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0950","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12964-023-01076-6","article-title":"Eukaryotic initiation factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity","volume":"21","author":"Mart\u00ednez-F\u00e9rriz","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189683_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110453","article-title":"Polyamines stimulate the protein synthesis of the translation initiation factor eIF5A2, participating in mRNA decoding, distinct from eIF5A1","volume":"301","author":"Suzuki","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189683_bb0960","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13578-021-00578-5","article-title":"EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGF\u03b2 pathway","volume":"11","author":"Zhao","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbcan.2026.189683_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216120","article-title":"Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation","volume":"559","author":"Coni","year":"2023","journal-title":"Cancer Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:26:12Z","timestamp":1789518372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":193,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X26001551"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189683","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189683"}}